| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/25/2001 | WO2001005956A2 Sialyation of n-linked glycoproteins in the baculovirus expression vector system |
| 01/25/2001 | WO2001005955A2 Animals comprising human hepatocellular tissue |
| 01/25/2001 | WO2001005947A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | WO2001005835A1 Inactivated vaccine against feline calicivirus disease |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005833A1 Odorant receptors |
| 01/25/2001 | WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | WO2001005827A1 Fima PILUS-BASED VACCINES |
| 01/25/2001 | WO2001005823A2 Tryptase inhibitor |
| 01/25/2001 | WO2001005815A1 Process for deacylation of lipodepsipeptides |
| 01/25/2001 | WO2001005801A1 Novel nucleic acid base pair |
| 01/25/2001 | WO2001005426A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 01/25/2001 | WO2001005355A2 Formulations for il-11 |
| 01/25/2001 | WO2000071566A3 Novel organic anion transport proteins |
| 01/25/2001 | WO2000068240A8 NOVEL aroA |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000058472A3 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 01/25/2001 | WO2000058465A3 Flint polypeptide analogs |
| 01/25/2001 | WO2000054580A3 Leukotriene b4 receptor transgenic mammals |
| 01/25/2001 | DE19933719A1 Strukturprotein in Adeno-assoziiertem Virus mit veränderten chromatographischen Eigenschaften, seine Herstellung und Verwendung Structural protein in adeno-associated virus with altered the chromatographic properties, its preparation and use |
| 01/25/2001 | DE19930959A1 Neue Antimycotika und Fungizide, Verfahren zu deren Herstellung und Verwendung New antimycotics and fungicides, processes for their preparation and use |
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2380000A1 Odorant receptors |
| 01/25/2001 | CA2379983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | CA2379968A1 Gtp-binding protein associated factors |
| 01/25/2001 | CA2379823A1 Real-time, in situ biomanufacturing process monitoring and control in response to ir spectroscopy |
| 01/25/2001 | CA2379627A1 Inhibitor proteins |
| 01/25/2001 | CA2379391A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | CA2379354A1 Formulations for il-115 |
| 01/25/2001 | CA2379349A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 01/25/2001 | CA2379129A1 Fima pilus-based vaccines |
| 01/25/2001 | CA2379069A1 Fimh adhesin-based vaccines |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378917A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | CA2378868A1 Process for deacylation of lipodepsipeptides |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/24/2001 | EP1070962A2 Method for detecting low density lipoprotein (LDL) or denatured low density lipoprotein in blood |
| 01/24/2001 | EP1070141A1 Immediate early genes and methods of use therefor |
| 01/24/2001 | EP1070133A2 Biological material with increased expression of endogenous complement regulatory molecules |
| 01/24/2001 | EP1070129A2 Dadd, death activator death domain protein |
| 01/24/2001 | EP1070128A1 Axor4 g-protein-coupled receptor |
| 01/24/2001 | EP1070125A2 Human nucleic acid sequences from normal breast tissue |
| 01/24/2001 | EP1070121A1 The cytokine family member ef-7 |
| 01/24/2001 | EP1070081A1 Novel molecules of the t129-related protein family and uses thereof |
| 01/24/2001 | EP1070080A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
| 01/24/2001 | EP0820471B1 Antibodies against heart muscle actin |
| 01/24/2001 | EP0599990B1 Hla typing |
| 01/24/2001 | CN1281468A Treatment with anti-ErbB2 antibodies |
| 01/24/2001 | CN1281051A Process for preparing bacterial cellulose by glucose oxidation and bacillus fermentation |
| 01/24/2001 | CN1280985A Recombined human hopatocyte auxin, its preparing process and its clinical application |
| 01/24/2001 | CN1280983A Derivant of interleukin-11 and its preparing process |
| 01/24/2001 | CN1061095C Process for preparing glycopeptide antibiotics |
| 01/23/2001 | US6177615 Lepidopteran-toxic polypeptide and polynucleotide compositions and methods for making and using same |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177545 Antibody which preferentially binds an epitope of an enzymatic protein; for diagnosis of time events in tumor propagation and metastasis, autoimmune diseases, kidney defects and atherosclerotic injury |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177257 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/23/2001 | US6177253 Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p24 |
| 01/23/2001 | US6177246 Contacting a tissue or cell with an oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding abnormally expressed beta-amyloid precursor protein; prophylaxis and treatment of alzheimer's disease |
| 01/23/2001 | US6177086 DNA molecule conferring on Mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates |
| 01/23/2001 | US6177081 Human and marmoset activating viruses |
| 01/23/2001 | US6177079 Monoclonal antibodies against interleukins |
| 01/18/2001 | WO2001004344A2 Induction of a th1-like response in vitro |
| 01/18/2001 | WO2001004329A1 Modified human granulocyte-colony stimulating factor and process for producing same |
| 01/18/2001 | WO2001004326A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 01/18/2001 | WO2001004312A1 Proliferation differentiation factor |
| 01/18/2001 | WO2001004308A1 Human lim domain proteins |
| 01/18/2001 | WO2001004306A1 Expression vectors and methods |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004304A1 Human cytokine receptor |
| 01/18/2001 | WO2001004300A1 Apoptosis-associated factor |
| 01/18/2001 | WO2001004299A1 AMYLOID β PROTEIN AGGLUTINATION CONTROLLING FACTOR |
| 01/18/2001 | WO2001004294A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | WO2001004292A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | WO2001004281A2 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | WO2001004269A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | WO2001004264A2 Atherosclerosis-associated genes |
| 01/18/2001 | WO2001004160A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |
| 01/18/2001 | WO2001004157A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 01/18/2001 | WO2001004156A1 Peptides that lower blood glucose levels |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004148A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | WO2001004144A2 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 01/18/2001 | WO2001004138A1 Dsra protein and polynucleotides encoding the same |
| 01/18/2001 | WO2001003737A1 Immunoglobulin fusion proteins |
| 01/18/2001 | WO2001003735A1 Cancer treatment using angiopoietins targeted to aminophospholipids |
| 01/18/2001 | WO2001003733A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | WO2001003726A1 Stable factor viii compositions |
| 01/18/2001 | WO2000068383A3 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 01/18/2001 | WO2000066755A3 Pesticidal fusions |
| 01/18/2001 | WO2000063415A8 Dna encoding the human vanilloid receptor vr1 |
| 01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000039304A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/18/2001 | WO2000023565B1 Novel neuropilin/growth factor binding and uses thereof |
| 01/18/2001 | WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/18/2001 | WO1999051756A3 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 01/18/2001 | DE19933288A1 Strukturprotein von Adeno-assoziiertem Virus mit veränderter Antigenität, seine Herstellung und Verwendung Structural protein of adeno-associated virus with altered antigenicity, its preparation and use |